Journal profile · Pathology
Seminars in Immunopathology
ISSN 1863-2297 · eISSN 1863-2300 · Springer Berlin Heidelberg · UNITED STATES · Quarterly · Founded 1978
Seminars in Immunopathology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.43; hybrid open access; APC about USD 3,790; median 188 days to acceptance (42 articles, last 24 months); community-reported acceptance: about 95%; 38 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Immunopathology is published by Springer Berlin Heidelberg and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 27.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The aim of this journal is to bring clinicians and pathologists up-to-date on developments in the field of immunopathology. For this purpose topical issues will be organized usually with the help of a guest editor. Recent developments are summarized in review articles by authors who have personally contributed to the specific topic. The pertinent literature is given at the end of each paper, not in an exhaustive way but so that the interested reader can easily orient himself by studying the key references.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Petra ArckPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named Germany 18, United States 5, Switzerland 3, United Kingdom 2, Japan 2 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology12.6%
- T-cell and B-cell ImmunologyImmunology and Microbiology8.2%
- Immunotherapy and Immune ResponsesImmunology and Microbiology7.1%
- Immune Response and InflammationImmunology and Microbiology5.8%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology5.5%
- Reproductive System and PregnancyImmunology and Microbiology5%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience4.8%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pathology | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.43LetPub ·
- Impact factor (publisher) 2025
- 11.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 12.2Publisher website ·
- CiteScore 2026-06
- 22.1LetPub ·
- SJR 2026-06
- 3.41LetPub ·
- SNIP 2026-06
- 2.41LetPub ·
- h-index
- 85LetPub ·
- h-index
- 146OpenAlex ·
- i10-index
- 865OpenAlex ·
- 2-year mean citedness
- 16.52OpenAlex ·
- Self-citation rate
- 0.9%LetPub ·
- Share of gold OA articles
- 70.51%LetPub ·
Volume
- Articles per year
- 36LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 888,300Publisher website ·
Articles by year OpenAlex count · 1,018 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 7 | 11 |
| 2025 | 38 | 29 | 563 |
| 2024 | 26 | 20 | 797 |
| 2023 | 21 | 17 | 619 |
| 2022 | 75 | 65 | 3,238 |
| 2021 | 72 | 48 | 3,180 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
188 daysMedian, submission to acceptance · P25–P75 104 days – 247 days
- Acceptance to online
- median 27 days (42 articles)
- Submission to online
- median 234 days
- Sample
- 42 articles with submission and acceptance dates (43 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 monthsLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
- Submission to first decision
- 16 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,790 / EUR 2,890 / GBP 2,490 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Seminars in Immunopathology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Journal publishes only invited review articles; unsolicited manuscripts not considered. Model summary
Please note that each issue of Seminars in Immunopathology is devoted to a specific topic, and organized by a guest editor who invites appropriate colleagues to contribute review articles to the issue. Thus, Seminars in Immunopathology publishes only invited review articles, and unsolicited manuscripts can unfortunately not be taken into consideration.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1978
- ISSN
- 1863-2297
- Electronic ISSN
- 1863-2300
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Immunopathology
What CAS zone is Seminars in Immunopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Immunopathology is in Zone 1 of Medicine, and in Zone 1 of the minor category Pathology / Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Immunopathology?
The latest impact factor listed by LetPub is 11.43; CiteScore 22.1, h-index 146.
How long does peer review take at Seminars in Immunopathology?
Based on the dates recorded on 42 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 188 days (interquartile range 104–247 days); authors report an average review time of about 12 months; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Seminars in Immunopathology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Seminars in Immunopathology based?
Of the 38 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are Germany (18), United States (5) and Switzerland (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Immunopathology?
According to LetPub and DOAJ records, Seminars in Immunopathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Seminars in Immunopathology open access, and what is the APC?
Seminars in Immunopathology is a hybrid journal. For open-access publication: APC about USD 3,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .